LABELLED BRASSINOSTEROIDS
[2H3]BRASSINOLIDE(D-BI) [[26-2H3] (22R,23R,24S)-2α,3α,22,23-tetrahydroxy-24-methyl-B-homo-7-oxa-5α-cholestan-6-one]
|
MW 483.71; crystalline; purity > 95% (HPLC) |
|
CAS: 461670-12-2; C28H452H3O6 |
|
|
038 5891 |
100 |
µg |
|
038 5892 |
200 |
µg |
|
038 5893 |
500 |
µg |
[2H3]EPIBRASSINOLIDE(D-EBI) [[2H3]24-epibrassinolide, [26-2H3],(22R,23R,24R)-2α,3α,22,23-tetrahydroxy-24-methyl-B-homo-7-oxa-5α-cholestane-6-one]
|
MW 483.67; crystalline; purity > 98% (HPLC) |
|
CAS: 1316216-51-9; C28H452H3O6 |
|
|
038 0201 |
100 |
µg |
|
038 0202 |
200 |
µg |
|
038 0203 |
500 |
µg |
[2H3]BRASSINONE (D-NBk) [[2H3] 28-norcastasterone, [26-2H3] (22R,23R)- 2α,3α,22,23-tetrahydroxy-5α-cholestan-6-one]
|
MW 453.64; crystalline; purity > 98% (HPLC) |
|
CAS: 1632494-67-7; C27H432H3O5 |
|
|
038 5631 |
100 |
µg |
|
038 5632 |
200 |
µg |
|
038 5633 |
500 |
µg |
[2H3]CASTASTERONE(D-Bk) [[26-2H3] (22R,23R,24S)-2α,3α,22,23-tetrahydroxy-24-methyl-5α-cholestan-6-one]
|
MW 467.71; crystalline; purity > 94% (HPLC) |
|
CAS: 461670-13-3; C28H452H3O5 |
|
|
038 6651 |
100 |
µg |
|
038 6652 |
200 |
µg |
|
038 6653 |
500 |
µg |
[2H3]EPICASTASTERONE (D-EBk) [[2H3] 24-epicastasterone, [26-2H3] (22R,23R,24R)-2α,3α,22,23-tetrahydroxy-24-methyl-5α-cholestane-6-one]
|
MW 467.67; crystalline; purity > 98% (HPLC) |
|
CAS: 1316216-47-3; C28H452H3O5 |
|
|
038 0901 |
100 |
µg |
|
038 0902 |
200 |
µg |
|
038 0903 |
500 |
µg |
[2H3]CAMPESTANOL (D-CAMP) [[26-2H3](24R)-3-β-hydroxy-24-methyl-5α-cholestane]
| MW 405.69; crystalline; purity > 90% ( HPLC ) |
|
CAS: 1400878-56-9; C28H472H3O |
|
| 038 6781 |
100 |
µg |
| 038 6782 |
200 |
µg |
| 038 6783 |
500 |
µg |
[2H3]CATHASTERONE (D-CATH) [[22,26,26-2H3](22S,24R)-3-β,22-dihydroxy-24-methyl-5α-cholestane-6-one]
| MW 435.67; crystalline; purity > 95% ( HPLC ) |
|
CAS: 1380235-47-1; C28H452H3O3 |
|
| 038 6761 |
100 |
µg |
| 038 6762 |
200 |
µg |
| 038 6763 |
500 |
µg |
[2H3]6-DEOXO-24-EPICASTASTERONE (D-EBd) [[26-2H3](22R,23R,24R)-2α,3α,22,23-tetrahydroxy-24-methyl-5α-cholestane]
| MW 453.68, crystalline; purity >98% (HPLC) |
|
CAS: 1402912-18-8; C28H472H3O4 |
|
| 038
0921 |
100 |
µg |
| 038
0922 |
200
|
µg |
| 038
0923 |
500
|
µg |
[2H3]6-DEOXOCASTASTERONE (D-6deoxoCS) [[26-2H3](22R,23R,24R)-2α,3α,22,23-tetrahydroxy-24-methyl-5α-cholestane
| MW 453.68, crystalline; purity >98% (HPLC) |
|
CAS: 1402912-18-8; C28H472H3O4 |
|
| 038
7511 |
100 |
µg |
| 038
7512 |
200
|
µg |
| 038
7513 |
500
|
µg |
[2H3]6-DEOXYTYPHASTEROL (2H-6deoxoTY) [[26-2H3](3α,5α22R,23R,24S)-Ergostane-3,22,23-triol
| MW 437.68, crystalline; purity >90% (HPLC) |
|
CAS: 1449510-51-3; C28H472H3O3 |
|
| 038
7541 |
100 |
µg |
| 038
7542 |
200
|
µg |
| 038
7543 |
500
|
µg |
[2H3]6-DEOXYTYPHASTEROL (D-DECATH) [[26-2H3](22S,24R)-3-β,22-dihydroxy-24-methyl-5α-cholestane]
| MW 421.69; crystalline; purity > 98% ( HPLC ) |
|
CAS: 1449510-51-3; C28H472H3O2 |
|
| 038 6771 |
100 |
µg |
| 038 6772 |
200 |
µg |
| 038 6773 |
500 |
µg |
[2H3]CAMPESTEROL (D-CR) [[26-2H3](3S,8S,9S10R14S,17R)-17-[(2R,5R)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopentaphenanthren-3-ol]
| MW 403.67; crystalline; purity > 98% ( HPLC ) |
|
CAS: 1400878-52-5; C28H482H3O |
|
| 038 6921 |
100 |
µg |
| 038 6922 |
200 |
µg |
| 038 6923 |
500 |
µg |
[2H3]NORBRASSINOLIDE (D-NBI) [[2H3] 28-norbrassinolide, [26-2H3] (22R,23R)- 2α,3α,22,23-tetrahydroxy-B-homo-7-oxa-5α-cholestan-6-one]
|
MW 469.64; crystalline; purity > 98% (HPLC) |
|
CAS: 313350-52-6; C27H432H3O6 |
|
|
038 5621 |
100 |
µg |
|
038 5622 |
200 |
µg |
|
038 5623 |
500 |
µg |
[2H3]TYPHASTEROL (D-TY) [[26-2H3] 3,22,23-trihydroxy-(3α,5α,22R,23R,24S)-Ergostan-6-one]
|
MW 451.67; crystalline; purity > 90% (HPLC) |
|
CAS: 461670-14-4; C28H452H3O4 |
|
|
038 7161 |
100 |
µg |
|
038 7162 |
200 |
µg |
|
038 7163 |
500 |
µg |